Amber Salzman is the CEO of Epic Bio and an independent Board Director, recognized for her leadership in driving therapy development to address unmet medical needs. Her career is marked by extensive experience in the biotechnology and pharmaceutical sectors.
Prior to her current role at Epic Bio, Salzman served as CEO and President of Ohana Biosciences. She also led Adverum Biotechnologies, a company focused on gene therapy treatments for rare diseases and diseases of the eye.